Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer



Deep Vein Thrombosis and Pulmonary Embolism in the Apixaban Era: From Bench to Bedside

Volume:19   Issue: 6
Pp: 577-580
Pavel Poredos* and Mateja Kaja Jezovnik
DOI: 10.2174/1389450116666150518100106



To Bleed or Not to Bleed: That is the Question. The Side Effects of Apixaban

Volume:19   Issue: 6
Pp: 581-584
Marco Matteo Ciccone*, Annapaola Zito, Fiorella Devito, Maria Maiello and Pasquale Palmiero
DOI: 10.2174/1389450116666151001113932



New Advances in Atrial Fibrillation Management: The Role of Apixaban

Volume:19   Issue: 6
Pp: 585-592
Giuseppe M.C. Rosano, Ilaria Spoletini, Walter Gianni and Cristiana Vitale*
DOI: 10.2174/1389450118666171013095413



β3-Adrenoceptor Control of Lower Genitourinary Tract Organs and Function in Male: An Overview

Volume:19   Issue: 6
Pp: 602-612
Ecem Kaya, Suresh C Sikka, Didem Yilmaz Oral, Isil Ozakca and Serap Gur*
DOI: 10.2174/1389450118666170120165554



Drug Resistance of Enzalutamide in CRPC

Volume:19   Issue: 6
Pp: 613-620
Xuedong Chen, Jieyang Lu, Liqun Xia and Gonghui Li *
DOI: 10.2174/1389450118666170417144250



Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders

Volume:19   Issue: 6
Pp: 636-650
Paolo Boldrini*, Antonella Fusco, Ferdinando Nicoletti, Aldo Badiani and Luciano Saso
DOI: 10.2174/1389450118666170425153356



GRP78 Influences Chemoresistance and Prognosis in Cancer

Volume:19   Issue: 6
Pp: 701-708
Jenifer B. Gifford and Reginald Hill*
DOI: 10.2174/1389450118666170615100918